|
PTPN21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.43267686182025E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80609971422996E-11 |
| Normal-vs-Stage2 |
6.95879998069415E-09 |
| Normal-vs-Stage3 |
1.22270005231684E-09 |
| Normal-vs-Stage4 |
1.19860010805439E-10 |
| Stage1-vs-Stage2 |
2.018800E-01 |
| Stage1-vs-Stage3 |
2.568200E-01 |
| Stage1-vs-Stage4 |
1.322120E-03 |
| Stage2-vs-Stage3 |
7.867000E-01 |
| Stage2-vs-Stage4 |
1.797410E-01 |
| Stage3-vs-Stage4 |
9.831600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35850219962208E-11 |
| Normal-vs-AfricanAmerican |
5.38270539252039E-11 |
| Normal-vs-Asian |
7.11859999835696E-08 |
| Caucasian-vs-AfricanAmerican |
3.821600E-01 |
| Caucasian-vs-Asian |
4.240400E-03 |
| AfricanAmerican-vs-Asian |
1.254810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93265411954735E-12 |
| Normal-vs-Female |
1.54670000140911E-08 |
| Male-vs-Female |
4.125200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.12609999103341E-09 |
| Normal-vs-Extreme_Weight |
3.1511016018726E-11 |
| Normal-vs-Obese |
2.9700000236943E-09 |
| Normal-vs-Extreme_Obese |
2.48730000040887E-07 |
| Normal_Weight-vs-Extreme_Weight |
6.330600E-01 |
| Normal_Weight-vs-Obese |
4.169600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.672000E-01 |
| Extreme_Weight-vs-Obese |
7.095400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.595200E-01 |
| Obese-vs-Extreme_Obese |
3.882800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56399998402424E-09 |
| Normal-vs-Age(41-60Yrs) |
1.64339997166252E-09 |
| Normal-vs-Age(61-80Yrs) |
2.13096207346553E-12 |
| Normal-vs-Age(81-100Yrs) |
4.46889999450306E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.154100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.572600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.198200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.291900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.363350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.632400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.71079977646139E-10 |
| Normal-VS-Type2 PRCC |
2.24265050974282E-14 |
| Normal-VS-KIRP CIMP |
8.08800026952383E-10 |
| Normal-VS-Unclassified PRCC |
4.19350000000485E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.392500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.482000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.749000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.388200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.254200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.121500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
2.50349996289145E-09 |
| Normal-vs-N2 |
4.68870000047694E-07 |
| N0-vs-N1 |
5.922000E-01 |
| N0-vs-N2 |
7.504300E-02 |
| N1-vs-N2 |
1.117630E-01 |
|
|
